Bharat Biotech has gained the `Greatest Manufacturing /Course of Improvement’ award as a part of the Vaccine Business Excellence (ViE) awards on the World Vaccine Congress 2023.
The Congress was held throughout April 3-6 in Washington, USA.
Hyderabad-based Bharat Biotech was the one Indian firm within the checklist of VIE awards in varied classes, together with greatest scientific trial firm, greatest scientific trial community, greatest central/specialty laboratory award, greatest contract analysis organisation, greatest manufacturing/course of growth award, amongst others.
Learn additionally: Extra energy for pharma
Bharat Biotech is the world’s first producer of intranasal Covid-19 vaccine, iNcovacc. Its intramuscular vaccine, Covaxin, is a part of India’s public vaccination programme and was additionally exported.
Learn extra: All about iNcovacc, the intranasal Covid-19 vaccine of Bharat Biotech
The World Vaccine Congress is the most important world assembly devoted to vaccines. From primary analysis to industrial manufacture, it covers the entire vaccine worth chain. Aside from uniting vaccine specialists, it was instrumental in sharing groundbreaking data in tackling the pandemic.
